Parallax Volatility Advisers’s Intelligent Medicine Acquisition Corp. Class A Common Stock IQMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-14,333
Closed -$144K 3426
2022
Q3
$144K Buy
+14,333
New +$144K ﹤0.01% 2403

Other funds holding IQMD

Parallax Volatility Advisers's IQMD Position: Q4 2022 in Review

Parallax Volatility Advisers sold out of Intelligent Medicine Acquisition Corp. Class A Common Stock (IQMD) in Q4 2022, closing a stake of 14,333 shares — an estimated $144K sold.

Parallax Volatility Advisers first reported a position in IQMD in Q3 2022 and held it in 1 quarter. The position peaked at $144K in Q3 2022. 60 funds tracked by Wall St. Rank hold IQMD as of Q4 2022.

  • Parallax Volatility Advisers reported no remaining Intelligent Medicine Acquisition Corp. Class A Common Stock position as of Q4 2022 after selling out during the quarter.
  • Parallax Volatility Advisers sold 14,333 Intelligent Medicine Acquisition Corp. Class A Common Stock shares in Q4 2022, an estimated $144K.
  • Parallax Volatility Advisers first reported a position in Intelligent Medicine Acquisition Corp. Class A Common Stock in Q3 2022 and held it in 1 quarter.
  • Parallax Volatility Advisers's Intelligent Medicine Acquisition Corp. Class A Common Stock position peaked at $144K in Q3 2022.
  • 60 funds tracked by Wall St. Rank held Intelligent Medicine Acquisition Corp. Class A Common Stock as of Q4 2022.

Based on Parallax Volatility Advisers's 13F filing for Q4 2022, filed 14 Feb 2023.